Form 6-K Brookfield Business Corp For: Feb 03 Filed by: Brookfield Business Partners L.P.
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2023
Commission File Number: 001-37775 | Commission file number 001-41313 |
Brookfield Business Partners L.P. (Exact name of Registrant as specified in its charter) | BROOKFIELD BUSINESS CORPORATION |
73 Front Street, 5th Floor Hamilton, HM 12 Bermuda (Address of principal executive office) | 250 Vesey Street, 15th Floor New York, New York 10281 (Address of principal executive office) |
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
EXHIBIT INDEX
Exhibit Number | Description | |
99.1 | Press Release dated February 3, 2023 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Brookfield Business Partners L.P. | ||
by its general partner, Brookfield Business Partners Limited | ||
Date: February 3, 2023 | By: | /s/ Jane Sheere |
Name: Jane Sheere | ||
Title: Corporate Secretary | ||
BROOKFIELD BUSINESS CORPORATION | ||
Date: February 3, 2023 | By: | /s/ Jaspreet Dehl |
Name: Jaspreet Dehl | ||
Title: Chief Financial Officer |
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Checkpoint Therapeutics (CKPT) Announces $6.1 Million Registered Direct Offering of Common Stock, Warrants
- Biomea Fusion (BMEA) Prices Upsized 5M Share Offering at $30/sh
- Tiziana Life Sciences (TLSA) Announces Presentation of Anti-CD3 mAb Research for the Treatment of Alzheimer’s Disease
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S3Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!